NAFLD-related HCC

被引：17

作者：

Banini, Bubu A. ^{[1
]}

Sanyal, Arun J. ^{[2
]}

机构：

[1] Yale Univ, Sect Digest Dis, New Haven, CT USA

[2] Virginia Commonwealth Univ, Div Gastroenterol Hepatol & Nutr, Richmond, VA 23298 USA

来源：

MECHANISMS AND THERAPY OF LIVER CANCER | 2021年 / 149卷

关键词：

FATTY LIVER-DISEASE; NUTRITION EXAMINATION SURVEY; CHRONIC HEPATITIS-C; HEPATOCELLULAR-CARCINOMA; NONALCOHOLIC STEATOHEPATITIS; UNITED-STATES; NATURAL-HISTORY; CRYPTOGENIC CIRRHOSIS; METABOLIC SYNDROME; CONFERS SUSCEPTIBILITY;

D O I：

10.1016/bs.acr.2020.11.001

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Nonalcoholic fatty liver disease (NAFLD) is one of the major drivers for the rising trend in hepatocellular carcinoma (HCC). Over the past three decades, the incidence of both NAFLD and HCC have increased two- to threefold. It has been forecasted that the number of patients with NAFLD in the Unites States will reach 101 million by 2030; global increase is also foreseen. This trend will likely continue to translate into increased HCC in the Unites States and across the globe. In this chapter, we summarize the current evidence linking NAFLD, metabolic syndrome, particularly obesity and type 2 diabetes mellitus, and HCC. We describe the main molecular mechanisms connecting these metabolic perturbations and hepatocarcinogenesis.

引用

页码：143 / 169

页数：27

共 136 条

[121] Obesity and cancer risk: evidence, mechanisms, and recommendations [J].

Vucenik, Ivana ;

Stains, Joseph P. .

NUTRITION AND PHYSICAL ACTIVITY IN AGING, OBESITY, AND CANCER, 2012, 1271 :37-43

[122] Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma [J].

Weinmann, Arndt ;

Alt, Yvonne ;

Koch, Sandra ;

Nelles, Carina ;

Dueber, Christoph ;

Lang, Hauke ;

Otto, Gerd ;

Zimmermann, Tim ;

Marquardt, Jens U. ;

Galle, Peter R. ;

Woerns, Marcus A. ;

Schattenberg, Joern M. .

BMC CANCER, 2015, 15

[123] Metabolic Activation of lntrahepatic CD8+ T Cells and NKT Cells Causes Nonalcoholic Steatohepatitis and Liver Cancer via Cross-Talk with Hepatocytes [J].

Wolf, Monika Julia ;

Adili, Arlind ;

Piotrowitz, Kira ;

Abdullah, Zeinab ;

Boege, Yannick ;

Stemmer, Kerstin ;

Ringelhan, Marc ;

Simonavicius, Nicole ;

Egger, Michele ;

Wohlleber, Dirk ;

Lorentzen, Anna ;

Einer, Claudia ;

Schulz, Sabine ;

Clavel, Thomas ;

Protzer, Ulrike ;

Thiele, Christoph ;

Zischka, Hans ;

Moch, Holger ;

Tschoep, Matthias ;

Tumanov, Alexei V. ;

Haller, Dirk ;

Unger, Kristian ;

Karin, Michael ;

Kopf, Manfred ;

Knolle, Percy ;

Weber, Achim ;

Heikenwalder, Mathias .

CANCER CELL, 2014, 26 (04) :549-564

[124] Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States [J].

Wong, Robert J. ;

Aguilar, Maria ;

Cheung, Ramsey ;

Perumpail, Ryan B. ;

Harrison, Stephen A. ;

Younossi, Zobair M. ;

Ahmed, Aijaz .

GASTROENTEROLOGY, 2015, 148 (03) :547-555

[125] Nonalcoholic Steatohepatitis Is the Most Rapidly Growing Indication for Liver Transplantation in Patients With Hepatocellular Carcinoma in the U. S. [J].

Wong, Robert J. ;

Cheung, Ramsey ;

Ahmed, Aijaz .

HEPATOLOGY, 2014, 59 (06) :2188-2195

[126]

WOSTMANN BS, 1983, LAB ANIM SCI, V33, P46

[127] Adiponectin induces apoptosis in hepatocellular carcinoma through differential modulation of thioredoxin proteins [J].

Xing, Su-Qian ;

Zhang, Chen-Guang ;

Yuan, Ji-Fang ;

Yang, Hui-Min ;

Zhao, Shu-Dong ;

Zhang, Hong .

BIOCHEMICAL PHARMACOLOGY, 2015, 93 (02) :221-231

[128] Targeting the Ras/Raf/MEK/ERK pathway in hepatocellular carcinoma [J].

Yang, Sufang ;

Liu, Guohua .

ONCOLOGY LETTERS, 2017, 13 (03) :1041-1047

[129] Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome [J].

Yoshimoto, Shin ;

Loo, Tze Mun ;

Atarashi, Koji ;

Kanda, Hiroaki ;

Sato, Seidai ;

Oyadomari, Seiichi ;

Iwakura, Yoichiro ;

Oshima, Kenshiro ;

Morita, Hidetoshi ;

Hattori, Masahisa ;

Honda, Kenya ;

Ishikawa, Yuichi ;

Hara, Eiji ;

Ohtani, Naoko .

NATURE, 2013, 499 (7456) :97-+

[130] Should we undertake surveillance for HCC in patients with NAFLD? [J].

Younes, Ramy ;

Bugianesi, Elisabetta .

JOURNAL OF HEPATOLOGY, 2018, 68 (02) :326-334

← 5 6 7 8 9 10 11 12 13 14 →